Annual EBITDA
-$16.94 M
+$4.91 M+22.45%
31 December 2023
Summary:
Virpax Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization is currently -$16.94 million, with the most recent change of +$4.91 million (+22.45%) on 31 December 2023. During the last 3 years, it has fallen by -$4.98 million (-41.60%). VRPX annual EBITDA is now -545.08% below its all-time high of -$2.63 million, reached on 31 December 2018.VRPX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$1.91 M
+$1.53 M+44.36%
30 September 2024
Summary:
Virpax Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization is currently -$1.91 million, with the most recent change of +$1.53 million (+44.36%) on 30 September 2024. Over the past year, it has increased by +$4.40 million (+69.68%). VRPX quarterly EBITDA is now -210.72% below its all-time high of -$615.90 thousand, reached on 01 March 2020.VRPX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$14.97 M
+$4.08 M+21.42%
30 September 2024
Summary:
Virpax Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization is currently -$14.97 million, with the most recent change of +$4.08 million (+21.42%) on 30 September 2024. Over the past year, it has increased by +$2.10 million (+12.32%). VRPX TTM EBITDA is now -2156.52% below its all-time high of -$663.30 thousand, reached on 31 December 2019.VRPX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRPX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +69.7% | +12.3% |
| 3 y3 years | -41.6% | +53.5% | -25.1% |
| 5 y5 years | -432.4% | -188.5% | -2156.5% |
VRPX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -41.6% | +22.4% | -15.9% | +75.2% | -25.1% | +34.5% |
| 5 y | 5 years | -432.4% | +22.4% | -210.7% | +75.2% | -2156.5% | +34.5% |
| alltime | all time | -545.1% | +22.4% | -210.7% | +75.2% | -2156.5% | +34.5% |
Virpax Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.91 M(-44.4%) | -$14.97 M(-21.4%) |
| June 2024 | - | -$3.44 M(+4.1%) | -$19.05 M(+1.7%) |
| Mar 2024 | - | -$3.30 M(-47.7%) | -$18.72 M(+9.7%) |
| Dec 2023 | -$16.94 M(-22.5%) | -$6.31 M(+5.3%) | -$17.07 M(+23.2%) |
| Sept 2023 | - | -$5.99 M(+92.6%) | -$13.86 M(-11.0%) |
| June 2023 | - | -$3.11 M(+88.5%) | -$15.58 M(-15.2%) |
| Mar 2023 | - | -$1.65 M(-46.8%) | -$18.37 M(-15.9%) |
| Dec 2022 | -$21.85 M | -$3.10 M(-59.8%) | -$21.85 M(-4.4%) |
| Sept 2022 | - | -$7.72 M(+30.7%) | -$22.86 M(+24.7%) |
| June 2022 | - | -$5.90 M(+15.2%) | -$18.33 M(+24.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$5.12 M(+24.4%) | -$14.74 M(+23.2%) |
| Dec 2021 | -$11.96 M(+185.4%) | -$4.12 M(+29.2%) | -$11.96 M(+40.2%) |
| Sept 2021 | - | -$3.19 M(+38.0%) | -$8.53 M(+21.8%) |
| June 2021 | - | -$2.31 M(-1.7%) | -$7.01 M(+18.3%) |
| Mar 2021 | - | -$2.35 M(+241.9%) | -$5.92 M(+41.3%) |
| Dec 2020 | -$4.19 M(+31.7%) | -$686.90 K(-58.7%) | -$4.19 M(+0.6%) |
| Sept 2020 | - | -$1.66 M(+35.5%) | -$4.17 M(+66.3%) |
| June 2020 | - | -$1.23 M(+99.1%) | -$2.51 M(+95.9%) |
| Mar 2020 | - | -$615.90 K(-7.1%) | -$1.28 M(+92.9%) |
| Dec 2019 | -$3.18 M(+21.2%) | -$663.30 K | -$663.30 K |
| Dec 2018 | -$2.63 M | - | - |
FAQ
- What is Virpax Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Virpax Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals TTM EBITDA year-on-year change?
What is Virpax Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of VRPX is -$16.94 M
What is the all time high annual EBITDA for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high annual earnings before interest, taxes, depreciation & amortization is -$2.63 M
What is Virpax Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of VRPX is -$1.91 M
What is the all time high quarterly EBITDA for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$615.90 K
What is Virpax Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, VRPX quarterly earnings before interest, taxes, depreciation & amortization has changed by +$4.40 M (+69.68%)
What is Virpax Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of VRPX is -$14.97 M
What is the all time high TTM EBITDA for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high TTM earnings before interest, taxes, depreciation & amortization is -$663.30 K
What is Virpax Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, VRPX TTM earnings before interest, taxes, depreciation & amortization has changed by +$2.10 M (+12.32%)